v3.26.1
Balance Sheet Details (Tables)
 9 Months Ended
Jul. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents and Restricted Cash
As of
July 31, 2026October 31, 2025
In millions
Cash and cash equivalents $6,216 $5,773 
Restricted cash(1)
62 86 
Total$6,278 $5,859 
(1)    The Company included restricted cash in Other current assets in the accompanying Condensed Consolidated Balance Sheets.
Schedule of Inventory
Inventory
As of
July 31, 2026October 31, 2025
In millions
Purchased parts and fabricated assemblies$8,419 $4,139 
Finished goods3,404 2,213 
Total$11,823 $6,352 
Schedule of Property, Plant and Equipment
Property, Plant and Equipment, net
As of
July 31, 2026October 31, 2025
In millions
Land$249 $309 
Internal use software2,474 2,259 
Buildings and leasehold improvements1,855 2,075 
Machinery and equipment, including equipment held for lease7,858 7,987 
Gross property, plant and equipment12,436 12,630 
Accumulated depreciation(6,791)(6,628)
Property, plant and equipment, net$5,645 $6,002 
Schedule of Supplier Finance Program
The rollforward of outstanding obligations confirmed as valid under its supplier finance program for the nine months ended July 31, 2026, and the fiscal year ended October 31, 2025 were as follows:
As of
July 31, 2026October 31, 2025
In millions
Balance at beginning of period
$488 $466 
Invoices confirmed during the year
1,794 1,895 
Confirmed invoices paid during the year
(1,490)(1,873)
Balance at end of period
$791 $488 
Schedule of Changes in Aggregate Product Warranty Liabilities
The Company's aggregate product warranty liabilities and changes for the nine months ended July 31, 2026, and the fiscal year ended October 31, 2025 were as follows:
As of
July 31, 2026October 31, 2025
In millions
Balance at beginning of period$284 $301 
Charges99 206 
Adjustments related to pre-existing warranties(10)(55)
Settlements made (96)(168)
Balance at end of period(1)
$277 $284 
(1)The Company included the current portion in Other accrued liabilities, and amounts due after one year in Other non-current liabilities in the accompanying Condensed Consolidated Balance Sheets.
Schedule of Severance Liability and Severance Charges
The following table presents the activity related to the Company’s severance liability for the period indicated:
As of
July 31, 2026October 31, 2025
In millions
Balance at beginning of period$238 $49 
Severance charges120 418 
Cash paid and other(237)(229)
Balance at end of period$121 $238 
The following table presents severance charges as included in the Condensed Consolidated Statements of Earnings for the periods indicated:
For the three months ended July 31,For the nine months ended July 31,
2026202520262025
In millions
Cost of sales$14 $— $26 $63 
Research and development— — 7 31 
Selling, general and administrative15 — 41 147 
Acquisition, disposition and other charges9 15 46 15 
Total severance charges$38 $15 $120 $256 
Schedule of Accounts Receivable, Net
A summary of accounts receivable, net, including unbilled receivables was as follows:
As of
July 31, 2026October 31, 2025
In millions
Accounts receivable$5,821 $4,916 
Unbilled receivables380 396 
Allowances(16)(22)
Total$6,185 $5,290 
Schedule of Trade Receivables Sold and Cash Received
The allowances for credit losses related to accounts receivable and changes for the nine months ended July 31, 2026, and the fiscal year ended October 31, 2025 were as follows:
As of
July 31, 2026October 31, 2025
In millions
Balance at beginning of period$22 $10 
Provision for credit losses14 33 
Adjustments to existing allowances, including write offs(20)(21)
Balance at end of period$16 $22 
Schedule of Contract Liabilities
Contract liabilities consist of deferred revenue and customer deposits. A summary of contract liabilities were as follows:
As of
July 31, 2026October 31, 2025
LocationIn millions
Customer depositsOther accrued liabilities$348 $616 
Customer deposits - non-currentOther non-current liabilities57 72 
Total customer deposits$405 $688 
Deferred revenueDeferred revenue$5,561 $5,358 
Deferred revenue - non-currentOther non-current liabilities5,359 4,980 
Total deferred revenue$10,920 $10,338